BARCLAYS PLC: OFIX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of BARCLAYS PLC on OFIX, newest first. How the timeline and the estimate are built.
BARCLAYS PLC held 30,760 OFIX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 30,760 sharesChange vs previous 13F -5,227 shares
<0.01% of the 13F portfolio, value $281,147.
13F-HR 0000312069-26-000223 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 35,987 sharesChange vs previous 13F -99,490 shares
<0.01% of the 13F portfolio, value $412,771.
13F-HR 0000312069-26-000139 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F/A 135,477 sharesChange vs previous 13F +32,143 shares
<0.01% of the 13F portfolio, value $1,983,382.
13F-HR/A 0000312069-26-000090 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F/A 103,334 sharesChange vs previous 13F -17,742 shares
<0.01% of the 13F portfolio, value $1,685,377.
13F-HR/A 0000312069-26-000079 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F/A 121,076 sharesChange vs previous 13F -1,396 shares
<0.01% of the 13F portfolio, value $2,113,987.
13F-HR/A 0000312069-26-000080 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F/A 122,472 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,913,012.
13F-HR/A 0000312069-26-000089 filed by BARCLAYS PLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).